P3 Health Partners Inc (NASDAQ: PIII) is 10.27% higher on its value in year-to-date trading and has touched a low of $0.18 and a high of $1.44 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The PIII stock was last observed hovering at around $0.25 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $0.25, the stock is 16.98% and -7.63% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.16 million and changing -0.80% at the moment leaves the stock -49.18% off its SMA200. PIII registered -80.55% loss for a year compared to 6-month loss of -50.40%. The firm has a 50-day simple moving average (SMA 50) of $0.2685 and a 200-day simple moving average (SMA200) of $0.48802.
The stock witnessed a 11.91% gain in the last 1 month and extending the period to 3 months gives it a -34.08%, and is 18.66% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 15.21% over the week and 11.94% over the month.
P3 Health Partners Inc (PIII) has around 400 employees, a market worth around $88.28M and $1.48B in sales. Profit margin for the company is -6.95%. Distance from 52-week low is 40.03% and -82.78% from its 52-week high. The company has generated returns on investments over the last 12 months (-38.77%).
with sales reaching $378.88M over the same period.The EPS is expected to grow by 11.08% this year, but quarterly earnings will post 19.13% year-over-year. Quarterly sales are estimated to grow 9.23% in year-over-year returns.
P3 Health Partners Inc (PIII) Top Institutional Holders
69.0 institutions hold shares in P3 Health Partners Inc (PIII), with institutional investors hold 32.53% of the company’s shares. The shares outstanding are 161.97M, and float is at 91.41M with Short Float at 0.79%. Institutions hold 24.99% of the Float.
The top institutional shareholder in the company is ALYESKA INVESTMENT GROUP, L.P. with over 15.95 million shares valued at $7.18 million. The investor’s holdings represent 13.4152% of the PIII Shares outstanding. As of 2024-06-30, the second largest holder is ARMISTICE CAPITAL, LLC with 7.9 million shares valued at $3.56 million to account for 6.645 of the shares outstanding. The other top investors are AMERIPRISE FINANCIAL INC which holds 6.33 million shares representing 5.3228% and valued at over $2.85 million, while VANGUARD GROUP INC holds 1.5303 of the shares totaling 1.82 million with a market value of $0.82 million.
P3 Health Partners Inc (PIII) Insider Activity
The most recent transaction is an insider purchase by Chicago Pacific Founders UGP I, the company’s 10% Owner. SEC filings show that Chicago Pacific Founders UGP I bought 80,000 shares of the company’s common stock on Sep 12 ’24 at a price of $0.52 per share for a total of $41600.0. Following the purchase, the insider now owns 77.11 million shares.
P3 Health Partners Inc disclosed in a document filed with the SEC on Sep 13 ’24 that Chicago Pacific Founders UGP I (10% Owner) bought a total of 80,000 shares of the company’s common stock. The trade occurred on Sep 13 ’24 and was made at $0.50 per share for $39952.0. Following the transaction, the insider now directly holds 77.19 million shares of the PIII stock.
Still, SEC filings show that on Sep 11 ’24, Chicago Pacific Founders UGP I (10% Owner) acquired 80,000 shares at an average price of $0.56 for $44728.0. The insider now directly holds 77,025,438 shares of P3 Health Partners Inc (PIII).
